Skip to main content

Table 1 Patient Characteristics (Study A and B)

From: Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

Characteristic

Number

Age

63 (range 34-75)

ECOG PS 0*

3

ECOG PS 1

16

Males

12

Females

7

White

18

Hispanic

1

Prior surgery

6

Prior radiation

2

Prior chemotherapy regimens

 

1

5

2

8

≥ 3

2

  1. * ECOG PS: Eastern Co-operative Oncology Group Performance Status